Form 4 for INM InMed Pharmaceuticals Inc.
Accepted 2024-02-21 00:00:00 ET · period of report 2024-02-20 · accession 0001213900-24-015703 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-21 | 2024-02-20 | INM | ADAMS ERIC A | Pres, CEO, Dir | P - Purchase | $0.36 | +41.6K | 44.0K | +1,763% | +$15.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-02-20 | P | A | 41,600 | $0.36 | 43,959 | D | — | — |